Competitive binding assay (CBA) demonstrated that C225–G5–MTX exhibited a higher affinity for the EGFR-expressing rat glioma cell line (F98EGFR) than the wild-type rat glioma cell line (F98WT). This evidence concerns the gene EGFR and glioma.